1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
Biotech stocks are a staple among growth investors. The rewards can be staggering – prices on biotechnology shares can literally double overnight – but the risk is just as high. It’s not unusual...
These companies face challenges but have solid balance sheets and positive cash flow.
It’s easy to predict that a recession will come eventually. They always do. The trick is in the when – and even the most experienced experts take a lot of swings without making contact.
More Investing News »